Applied Immunology

CAR-T Cell Engineering and Optimization

Development of next-generation chimeric antigen receptor T cells with enhanced specificity, persistence, and reduced toxicity for cancer immunotherapy.

RESEARCH GAP FRONTIERS

Checkpoint Inhibitor Resistance Mechanisms

Investigation of tumor and immune cell adaptations that confer resistance to PD-1/PD-L1 and CTLA-4 blockade therapies.

RESEARCH GAP FRONTIERS

Therapeutic Vaccine Design and Development

Creation of personalized and off-the-shelf cancer and infectious disease vaccines utilizing neoantigen and immunogenic epitope identification.

RESEARCH GAP FRONTIERS

Mucosal Immunity and Barrier Function

Study of immune mechanisms at epithelial surfaces and development of mucosal vaccination strategies for respiratory and gastrointestinal pathogens.

RESEARCH GAP FRONTIERS

Immune Tolerance Engineering for Transplantation

Development of strategies to induce operational tolerance and reduce immunosuppressive burden in solid organ and cellular transplantation.

RESEARCH GAP FRONTIERS

Microbiota-Immune System Interactions

Investigation of how commensal bacteria influence immune homeostasis, vaccine efficacy, and response to immunotherapy.

RESEARCH GAP FRONTIERS

Innate Lymphoid Cell Biology and Function

Characterization of innate lymphoid cell subsets and their therapeutic potential in immune defense and tissue homeostasis.

RESEARCH GAP FRONTIERS

Regulatory T Cell Manipulation Strategies

Engineering and expansion of regulatory T cells for autoimmune disease and transplantation rejection prevention.

RESEARCH GAP FRONTIERS

Neutrophil Extracellular Traps and Pathology

Study of neutrophil extracellular trap formation and inhibition in inflammatory diseases, sepsis, and cancer metastasis.

Single-Cell Immunogenomics Technologies

Development and application of high-throughput single-cell sequencing methods to map immune cell phenotypes and functional states.

Dendritic Cell Engineering for Immunotherapy

Design of ex vivo generated and genetically modified dendritic cells for enhanced antigen presentation and T cell activation.

Immunometabolism and Cellular Reprogramming

Investigation of metabolic pathways regulating immune cell differentiation and function for therapeutic metabolic manipulation.

Antibody Engineering and Optimization

Development of bispecific, trispecific, and multispecific antibodies with enhanced Fc effector functions and reduced immunogenicity.

Immune Checkpoint Modulation in Solid Tumors

Strategies for overcoming cold tumor immunophenotypes through combinatorial checkpoint blockade and immune infiltration enhancement.

NK Cell Receptor Signaling Pathways

Characterization of natural killer cell activating and inhibitory receptor engagement for cancer and viral infection control.

Tissue-Resident Memory Cell Generation

Strategies to promote formation and persistence of tissue-resident memory T and B cells at mucosal and peripheral sites.

Immunoglobulin Class Switching Mechanisms

Molecular mechanisms regulating antibody isotype switching and therapeutic modulation for enhanced immune responses.

Therapeutic Monoclonal Antibody Manufacturing

Bioprocess optimization and cell engineering for large-scale production of therapeutic antibodies with consistent quality attributes.

Cytokine Signaling in Immune Activation

Investigation of JAK-STAT, PI3K, and MAPK pathways in lymphocyte activation and development of targeted cytokine therapeutics.

Bacterial Infection Immunology

Study of immune responses to intracellular and extracellular bacterial pathogens and development of infection-preventing vaccines.

Viral Vector Immunogenicity Management

Engineering of viral vectors and transgene expression systems to minimize innate immune activation while maintaining immunogenicity.

Immune Aging and Senescence Reversal

Investigation of immunosenescence mechanisms and development of rejuvenation strategies to restore age-related immune function.

B Cell Affinity Maturation and Selection

Characterization of germinal center dynamics and enhancement of high-affinity antibody production through engineered selection pressures.

Immune Metabolite Production and Function

Study of immunometabolites including succinate, itaconate, and tryptophan metabolites as immune regulators and therapeutic targets.

Parasitic Infection Immunotherapy

Development of immune-enhancing strategies and vaccines targeting helminth and protozoan parasites with complex immune evasion.

Complement Pathway Modulation Therapy

Therapeutic targeting of complement components for autoimmune diseases, inflammation, and enhancement of antibody-mediated immunity.

Immune Tolerance Biomarkers Discovery

Identification of cellular and molecular signatures predicting immune tolerance development after transplantation or immunotherapy.

Engineered Oncolytic Virus Immunotherapy

Development of armed oncolytic viruses expressing immunostimulatory molecules for enhanced tumor infiltration and systemic immunity.

Bispecific T Cell Engager Technology

Engineering of bispecific antibodies simultaneously engaging T cell receptors and tumor-associated antigens for cancer immunotherapy.

Autoimmune Disease Immune Mechanisms

Investigation of self-tolerance breakdown and aberrant immune responses in autoimmune conditions for targeted therapeutic intervention.

Immune Cell Trafficking and Homing

Study of adhesion molecules and chemokine gradients directing immune cell migration to specific tissues and lymphoid organs.

Nanoparticle-Based Immunotherapy Delivery

Development of nanoparticles as carriers for antigens, adjuvants, and immunomodulatory agents with targeted immune activation.

Immune Exhaustion Reversal in Chronic Infection

Strategies to restore effector functions in exhausted T cells during persistent viral infections and chronic immune stimulation.

Allergic Response Immunotherapy Development

Design of allergen-specific immunotherapies promoting immune tolerance through regulatory T cell and B cell induction.

Macrophage Polarization and Reprogramming

Manipulation of macrophage M1/M2 differentiation and metabolic states for tumor immunity and inflammatory disease treatment.

Peptide and Protein Immunogenicity Prediction

Machine learning approaches to predict MHC binding, T cell epitopes, and immunogenicity of therapeutic proteins and vaccines.

Engineered Immune Cell Safety and Control

Development of safety switches and control mechanisms for adoptive cellular therapies including suicide genes and inducible systems.

Toll-Like Receptor Ligand Development

Design of TLR agonists and antagonists as vaccine adjuvants and immunomodulatory agents with improved safety profiles.

Immune Response to Gene Therapy Vectors

Characterization and mitigation of innate and adaptive immune responses against viral and non-viral gene delivery systems.

Lymphoid Tissue Engineering and Reconstitution

Development of artificial lymph nodes and engineered lymphoid tissues for enhanced immune priming and vaccine efficacy.

Cancer Neoantigen Identification and Application

Computational and experimental methods for discovering patient-specific tumor mutations and engineering personalized neoantigen vaccines.

Innate Immune Training and Tolerance

Study of innate immune memory formation through trained immunity and tolerance mechanisms with therapeutic potential.

Immunotoxin Development and Refinement

Engineering of antibody-toxin conjugates with improved tumor selectivity, reduced off-target effects, and enhanced cytotoxicity.

Immune Cell Epigenetic Reprogramming

Manipulation of histone modifications and DNA methylation patterns to enhance or suppress immune cell differentiation and function.

Therapeutic Lipid Nanoparticle Formulations

Optimization of ionizable lipid composition and surface modification for mRNA vaccine and immunotherapy delivery with enhanced efficacy.

Immune Response to Cancer Immunotherapy

Investigation of immune activation patterns, T cell receptor clonality, and predictive biomarkers during checkpoint inhibitor treatment.

Antigen Processing and Presentation Enhancement

Strategies to improve proteasomal degradation, MHC loading, and cross-presentation of tumor and pathogen antigens.

Immune-Mediated Adverse Events Management

Study of immune checkpoint inhibitor-related toxicities and development of predictive biomarkers and mitigation strategies.

Vaccine Adjuvant Discovery and Optimization

Screening and development of novel adjuvants enhancing innate immune sensing and promoting appropriate adaptive immune responses.

Immune Cell Phenotyping by Flow Cytometry

High-dimensional flow cytometry panel development for comprehensive immune subset characterization in clinical and research settings.

Tissue-Specific Immune Microenvironment Profiling

Investigation of immune cell composition and spatial organization across different tissue types to understand organ-specific immune responses and therapeutic targeting strategies.

CRISPR-Enhanced T Cell Receptor Engineering

Development of CRISPR-Cas9 genome editing technologies to design T cells with optimized receptor specificity and enhanced anti-tumor functionality.

Metabolic Reprogramming in Anti-Tumor Immunity

Study of how manipulating immune cell metabolism through glycolysis and oxidative phosphorylation pathways enhances anti-cancer immune responses.

Tumor-Associated Macrophage Reprogramming Strategies

Development of therapeutic approaches to convert immunosuppressive tumor-associated macrophages into pro-inflammatory anti-tumor effectors.

Human Immunodeficiency Virus Immunotherapy Integration

Design of immune-based therapeutic strategies that harness CD8 T cell responses and broadly neutralizing antibodies for HIV cure research.

Engineered Extracellular Vesicle Immunotherapeutics

Creation of modified exosomes and microvesicles as delivery platforms for immunomodulatory molecules and antigen presentation to immune cells.

Inflammasome Activation and Regulation Mechanisms

Investigation of NOD-like receptor protein complex assembly and its therapeutic modulation in inflammatory and infectious diseases.

Therapeutic Antibody Half-Life Extension Technologies

Development of protein engineering approaches including Fc region modifications and albumin-binding domains to prolong antibody serum persistence.

Cancer Immunotherapy Combination Strategy Optimization

Systematic investigation of synergistic effects between checkpoint inhibitors, adoptive cell therapy, and targeted therapies in preclinical and clinical settings.

Pathogen-Associated Molecular Pattern Recognition

Study of pattern recognition receptor interactions with pathogenic and vaccine antigens to enhance innate immune activation and adaptive responses.

Type I Interferon Signaling in Antiviral Immunity

Investigation of JAK-STAT pathway activation downstream of interferon receptors and optimization for enhanced viral control and vaccine responses.

Immune Checkpoint Triple Modulation Approaches

Exploration of simultaneous targeting of multiple inhibitory pathways including PD-1, TIM-3, and LAG-3 to overcome immunosuppression in advanced cancers.

B Cell Receptor Signaling Threshold Manipulation

Characterization and therapeutic modulation of B cell activation thresholds to enhance antibody responses while preventing autoimmune pathology.

Respiratory Syncytial Virus Immunotherapy Development

Design of immunological approaches to generate balanced Th1/Th2 responses and tissue-resident memory cells against respiratory syncytial virus infection.

Glycosylation Engineering in Therapeutic Proteins

Optimization of N-linked and O-linked glycosylation patterns on antibodies and Fc-fusion proteins to enhance effector functions and reduce immunogenicity.

Natural Killer T Cell Activation and Expansion

Development of protocols to selectively expand invariant and variable NKT cells using glycolipid antigens for cancer immunotherapy applications.

Hypoxia-Driven Immune Suppression in Tumors

Investigation of HIF-1 alpha signaling in immune cells within hypoxic tumor microenvironments and therapeutic strategies to reverse immunosuppression.

Influenza-Specific Memory B Cell Persistence

Study of long-lived bone marrow plasma cell maintenance and germinal center dynamics following influenza vaccination and infection.

Systemic Lupus Erythematosus Immune Tolerance

Investigation of B cell tolerance mechanisms and therapeutic restoration of regulatory T cell function in lupus-prone mouse models and patient populations.

Engineered Minimal Epitope Peptide Vaccines

Design of synthetic peptide vaccines incorporating MHC-optimized epitopes and pattern recognition receptor ligands for rapid immune response generation.

Immune Cell Lipid Metabolism and Function

Investigation of cholesterol synthesis, fatty acid oxidation, and lipid storage in T cells, B cells, and macrophages to enhance immunotherapy efficacy.

Toxoplasma Gondii Immunoevasion Mechanisms

Study of parasite-derived immunosuppressive factors and development of immunotherapies to enhance protective Th1 responses and prevent reactivation.

Tumor-Infiltrating Lymphocyte Expansion Technologies

Development of ex vivo expansion protocols for therapeutic tumor-infiltrating lymphocytes with enhanced specificity and proliferative capacity.

Antigen Cross-Presentation Pathway Optimization

Investigation of dendritic cell mechanisms for presenting exogenous antigens on MHC-I molecules to enhance CD8 T cell immunotherapy responses.

Mycobacterium Tuberculosis Immune Escape Strategies

Characterization of pathogenic mechanisms that subvert innate immunity and development of immunotherapies to restore protective Th1 cell responses.

Engineered Interleukin Cytokine Agonists

Rational design of mutant interleukin variants with enhanced receptor selectivity and reduced systemic toxicity for therapeutic cancer immunotherapy.

Epstein-Barr Virus Associated Malignancy Prevention

Development of prophylactic and therapeutic vaccines targeting Epstein-Barr virus to prevent lymphoid malignancies and nasopharyngeal carcinoma.

Soluble Immune Checkpoint Receptor Therapeutics

Engineering of decoy receptors and fusion proteins that capture inhibitory ligands to reverse immune exhaustion in chronic infections and cancer.

Fungal Infection Immunotherapy and Vaccination

Development of immune-based therapeutic strategies against invasive fungal pathogens including Candida and Aspergillus through Th17 cell targeting.

Intestinal Barrier Function and Immune Homeostasis

Study of epithelial tight junction maintenance and therapeutic modulation of intestinal immune responses in inflammatory bowel disease models.

Programmed Death Ligand Expression Regulation

Investigation of transcriptional and post-translational mechanisms controlling PD-L1 and PD-L2 expression to predict and overcome checkpoint inhibitor resistance.

Myeloid-Derived Suppressor Cell Differentiation Inhibition

Development of strategies to prevent myeloid-derived suppressor cell expansion and reprogram existing cells toward anti-tumor phenotypes.

Type 2 Diabetes Immune Dysfunction Reversal

Investigation of glucose metabolism effects on immune cell function and therapeutic approaches to restore antiviral and anti-tumor immunity in diabetic patients.

Persistent Viral Infection Immune Escape

Study of viral mechanisms inducing T cell exhaustion in chronic hepatitis C and cytomegalovirus infections and immunotherapy interventions for viral clearance.

Engineered Antibody Fc Receptor Selectivity

Design of antibodies with altered Fc region binding preferences to selectively activate FcγRII or FcγRIII for enhanced ADCC or reduced cytotoxicity.

Rheumatoid Arthritis Immune Tolerance Induction

Development of antigen-specific and non-specific immunotherapies to suppress autoreactive B and T cell responses in rheumatoid arthritis.

Rotavirus-Induced Barrier Dysfunction Prevention

Study of rotavirus mechanisms that compromise intestinal barrier function and immunotherapy approaches to prevent pathology while maintaining adaptive immunity.

Immune Cell Senescence and Rejuvenation Factors

Investigation of molecular drivers of immune cell aging and therapeutic interventions to reverse senescence and restore effector function in elderly populations.

Engineered T Cell Receptor Affinity Optimization

Rational design and directed evolution of T cell receptors with enhanced tumor antigen recognition while maintaining MHC-peptide specificity.

Schistosomiasis Haematobium Immune Pathology

Study of Th2-skewed immune responses in schistosome infection and development of immunotherapies to shift toward protective Th1 cell responses.

Immune Activation in Sterile Tissue Injury

Investigation of damage-associated molecular pattern recognition and inflammasome activation in sterile trauma and development of immunosuppressive therapeutics.

Chimeric Antigen Receptor Macrophage Engineering

Development of CAR-engineered macrophages as enhanced phagocytic and antigen-presenting cells for improved solid tumor infiltration and immunotherapy.

Varicella-Zoster Virus Memory Maintenance

Study of herpes zoster reactivation mechanisms and immune-based strategies to boost tissue-resident memory T cells and prevent recurrent infection.

Immune Tolerance in Allografted Tissues

Investigation of transplant acceptance mechanisms including regulatory T cells and donor-specific antibodies for development of tolerance-inducing protocols.

Helminths-Induced Immune Modulation Reversal

Study of parasitic helminth-induced immunosuppression mechanisms and therapeutic strategies to restore Th1 and Th2 responses for parasite clearance.

Immune Metabolic Profiling by Mass Spectrometry

Application of metabolomic and proteomic technologies to characterize immune cell functional states and identify biomarkers for immunotherapy responsiveness.

Engineered Tumor-Targeting Cytokine Immunotherapy

Design of tumor-localized cytokine delivery systems using engineered antibodies or cell-based platforms to enhance anti-tumor immunity with reduced systemic toxicity.

Coccidioides Immitis Infection Immune Response

Investigation of Th1 and Th2 balance in coccidioidal infection and development of immunotherapies to prevent disseminated disease and chronic inflammation.

Tumor Microbiota-Mediated Immunotherapy Response

Study of intratumoral microbiota effects on immunotherapy efficacy and therapeutic approaches to optimize microbial composition for enhanced immune activation.

Immune Cytokine Storm Prevention Strategies

Development of immunomodulatory approaches to prevent excessive pro-inflammatory cytokine production while maintaining protective anti-pathogen immunity.

Engineered Probiotics for Mucosal Immunotherapy

Design and development of genetically modified commensal bacteria to deliver immunomodulatory agents directly to mucosal surfaces for therapeutic benefit.

Spatial Transcriptomics in Tumor Microenvironments

Integration of high-resolution spatial analysis with transcriptomic profiling to map immune cell interactions within complex tumor tissue architectures.

Synthetic Notch Receptor Engineering for T Cells

Development of engineered Notch signaling circuits to enhance T cell specificity, persistence, and function in immunotherapy applications.

Immunological Memory Formation in Elderly Populations

Investigation of age-related defects in germinal center reactions and memory cell establishment to improve vaccine efficacy in geriatric cohorts.

Interferon Signaling in Antiviral Immunity

Characterization of type I, II, and III interferon pathways in coordinating innate and adaptive immune responses against viral pathogens.

Tumor-Associated Macrophage Reprogramming Strategies

Development of therapeutic approaches to convert immunosuppressive tumor-associated macrophages into pro-inflammatory, tumor-killing phenotypes.

Peptide-MHC Binding Prediction Machine Learning

Creation of deep learning models integrating structural biology and immunoinformatics to predict immunogenic peptide-MHC interactions across populations.

Immune Checkpoints in Chronic Viral Infections

Mapping of programmed death and exhaustion markers in persistent viral infections to identify optimal combination immunotherapy targets.

Functional Antibody Glycoengineering Applications

Modification of antibody N-glycans to enhance Fc receptor engagement, complement activation, and cellular effector functions.

Humanized Mouse Model Development and Validation

Engineering of mice with human immune system components to enable translational studies of human-specific immunotherapy candidates.

Immune Priming by Bacterial Lipopolysaccharides

Investigation of how endotoxin-mediated pattern recognition receptor activation shapes subsequent adaptive immune responses and vaccine efficacy.

Secreted Biomarker Discovery in Immunotherapy

Identification and validation of soluble factors in serum and tissue fluids that predict response to checkpoint inhibitor and cell therapy treatments.

Cross-Presentation Enhancement in Cancer Immunotherapy

Optimization of dendritic cell-mediated cross-presentation pathways to improve CD8 T cell priming against tumor-associated antigens.

Immune Tolerance in Fetal-Maternal Interface

Elucidation of mechanisms maintaining immune homeostasis at the placental barrier to understand and potentially harness for transplant tolerance.

Metabolic Checkpoint Inhibition in T Cells

Development of metabolic inhibitors targeting glycolysis and amino acid metabolism to enhance T cell effector functions and reduce exhaustion.

Biodegradable Immunology Scaffold Fabrication

Engineering of three-dimensional biomaterial scaffolds that recapitulate lymphoid tissue architecture while supporting immune cell proliferation and education.

Single-Domain Antibody Library Construction

Development of phage display and ribosome display platforms for generating llama-derived nanobody libraries with enhanced tissue penetration.

Immune Activation by Damage-Associated Molecular Patterns

Characterization of host-derived alarmin signaling through pattern recognition receptors in sterile inflammation and tissue injury responses.

Genetic Engineering of Therapeutic Antibodies

Rational design of antibody mutations to enhance half-life, reduce immunogenicity, and improve efficacy in clinical applications.

Mycobacterial Immune Evasion Mechanisms

Investigation of Mycobacterium tuberculosis pathogen strategies to persist within macrophages and strategies to overcome immune subversion.

Organ-on-Chip Immunological Modeling Systems

Development of microfluidic platforms that recreate tissue-immune cell interactions to model inflammation and immune responses in vitro.

Immuno-Oncology Response Prediction Algorithms

Creation of integrative computational models combining genomic, transcriptomic, and clinical data to predict patient response to immunotherapy.

Fc Receptor Polymorphism and Clinical Outcomes

Investigation of how FcγR and FcγRIIIa polymorphisms influence antibody effector functions and therapeutic efficacy across patient populations.

Fungal Pathogen-Immune Recognition Pathways

Characterization of C-type lectin receptor and TLR signaling in recognition of fungal antigens and antifungal immune response development.

Immune Cell Differentiation by Epigenetic Modification

Manipulation of chromatin remodeling complexes and histone deacetylase activity to direct immune cell lineage commitment and functional specialization.

Circulating Tumor DNA and Immune Prediction

Integration of cell-free DNA analysis with immune profiling to predict immunotherapy response and detect treatment resistance early.

Bivalent T Cell Engager Design and Manufacturing

Engineering of tandem single-chain variable fragments as improved alternatives to bispecific antibodies for T cell redirection.

Intestinal Barrier Dysfunction in Inflammatory Disease

Investigation of tight junction protein disruption and epithelial permeability in inflammatory bowel disease pathogenesis and immune mechanisms.

Immune Privilege in Immunologically Isolated Sites

Characterization of blood-brain and blood-testis barrier mechanisms that restrict immune infiltration and potential therapeutic exploitation strategies.

Therapeutic Resistance in Melanoma Immunotherapy

Investigation of acquired immune resistance mechanisms in melanoma following checkpoint inhibitor treatment and combination therapy approaches.

Engineered Cytokine-Receptor Signaling Complexes

Design of synthetic cytokine variants with enhanced receptor selectivity and reduced off-target toxicity for therapeutic applications.

Immune Response Heterogeneity Within Tumors

Single-cell analysis of spatial immune cell diversity within distinct tumor regions to identify immunologically hot and cold zones.

Lipid Mediator-Driven Resolution of Inflammation

Investigation of specialized pro-resolving mediators including lipoxins and resolvins in controlling inflammatory responses and promoting tissue repair.

Vaccine Platform Technologies for MRNA Immunogenicity

Optimization of mRNA delivery formulations and sequence engineering to enhance innate recognition and adaptive immune activation.

Mesenchymal Stem Cell Immunomodulation Mechanisms

Characterization of how bone marrow-derived stromal cells suppress and promote immune responses through paracrine signaling and cell contact.

High-Dimensional Flow Cytometry Data Analysis

Development of computational methods to identify rare immune populations and define functional states in complex multiparameter flow cytometry datasets.

Immunogenicity Assessment of Therapeutic Proteins

In vitro and in vivo methods to predict and characterize immune responses against biopharmaceuticals and genetic therapeutic agents.

Metabolic Reprogramming in Macrophage Activation

Investigation of how macrophages switch between oxidative phosphorylation and glycolysis during classical versus alternative activation states.

Combinatorial Immunotherapy Synergy Identification

Screening platforms and biomarker development to rationally identify synergistic combinations of immunotherapeutic agents with minimal off-target effects.

Bacterial Flagellar Protein Immunogenicity Engineering

Modification of flagellin and other bacterial pathogen-associated molecular patterns to enhance immunostimulatory properties for vaccine adjuvants.

Immune Cell Apoptosis and Clearance Pathways

Investigation of mechanisms promoting tolerogenic clearance of apoptotic immune cells and therapeutic manipulation to enhance immune homeostasis.

Immunological Memory in Skin-Associated Lymphoid Tissue

Investigation of cutaneous dendritic cells and skin-resident T cells in generating localized and systemic protective immune memory.

Immune-Mediated Rejection in Organ Transplantation

Characterization of T cell, B cell, and antibody-mediated rejection mechanisms to develop improved immunosuppressive and tolerance-inducing strategies.

Quorum Sensing in Pathogenic Immune Modulation

Investigation of how bacterial cell-to-cell communication regulates virulence factor expression and immune evasion in infection contexts.

Engineered Exosome-Based Vaccine Delivery

Development of extracellular vesicle platforms incorporating immunogenic antigens and adjuvants for cell-free immunotherapy approaches.

Immune Senescence in Chronic Infection Models

Investigation of persistent antigen-driven immune activation leading to T cell exhaustion and senescence in hepatitis C, HIV, and CMV.

Patient-Derived Organoid Immunotherapy Screening

Development of personalized tumor organoid platforms combined with patient immune cells to predict individual immunotherapy responses.

Immune Tolerance Reversal in Autoimmunity

Therapeutic strategies to break existing immune tolerance and induce productive immune responses against self-antigens in autoimmune disease.

Engineered Oncolytic Immunotherapy Combination Studies

Investigation of synergies between genetically modified oncolytic viruses and checkpoint inhibitors in activating antitumor immune responses.

Immune Checkpoint Ligand Heterogeneity

Investigation of structural and functional diversity of PD-L1, PD-L2, and B7 family ligands across tumor microenvironments to enhance therapeutic targeting strategies.

Tertiary Lymphoid Structure Formation Engineering

Development of strategies to induce and optimize ectopic lymphoid organ formation within tumors to enhance local immune infiltration and activation.

T Cell Exhaustion Epigenetic Remodeling

Exploration of histone modifications and chromatin accessibility changes in exhausted T cells to develop novel epigenetic-based reversal therapies.

Immunosuppressive Myeloid Cell Targeting

Development of therapeutic approaches to eliminate or reprogram tumor-associated myeloid-derived suppressor cells and monocytes in immunotherapy resistance.

Gut-Associated Lymphoid Tissue Immunomodulation

Study of systemic immune effects through targeted manipulation of GALT and investigation of oral immunotherapeutic delivery mechanisms.

Spatial Immunophenotyping and Image Analysis

Advanced computational analysis of immune cell distribution and interactions within tissue architecture using multiplexed imaging and machine learning approaches.

Engineered Antibody-Cell Conjugate Therapy

Design of chemical linkage strategies for coupling therapeutic antibodies directly to immune effector cells for enhanced targeted cytotoxicity.

Pathogen-Associated Molecular Pattern Discovery

Identification and characterization of novel microbial-derived immunogenic molecules for innate immune activation and vaccine development applications.

Immune Cell Glycosylation and Function

Mechanistic analysis of N-glycans and O-glycans on immune receptors and their roles in cell activation, trafficking, and therapeutic efficacy.

Adoptive T Cell Persistence Engineering

Genetic and metabolic optimization strategies to extend the survival and functionality of adoptively transferred T cell therapies in vivo.

Fibroblast-Immune Cell Crosstalk Modulation

Therapeutic targeting of cancer-associated fibroblasts and stromal-immune interactions to overcome immunotherapy resistance in solid tumors.

Immunological Memory in Aged Populations

Investigation of protective immunity generation and maintenance in elderly individuals to develop age-adapted immunotherapeutic strategies.

Antibody Fc-Effector Function Optimization

Engineering of immunoglobulin constant regions to maximize antibody-dependent cell-mediated cytotoxicity and complement activation for cancer therapy.

Immune Response to Synthetic Biology Circuits

Characterization of host immunogenicity against engineered genetic circuits and development of immunoevasion strategies for synthetic cell therapies.

Tumor-Infiltrating Lymphocyte Expansion Optimization

Development of culture conditions and stimulation strategies to maximize the expansion and functionality of tumor-derived T cells for adoptive therapy.

Bacterial Lipopolysaccharide Structure-Activity Relationships

Analysis of how LPS structural variants modulate innate immune activation patterns for adjuvant development and endotoxin mitigation strategies.

Immune Sequestration in Sanctuary Sites

Investigation of immune evasion mechanisms in immune-privileged sites and development of strategies to enhance immune access to sequestered pathogens.

Chimeric Antigen Receptor Signaling Domains

Rational design and optimization of CAR intracellular signaling modules to fine-tune T cell activation, proliferation, and cytokine production profiles.

Immunological Imprinting by Early Life Infections

Study of how early pathogenic exposures shape long-term immune responses and vulnerability to subsequent infections and autoimmunity.

Soluble Immune Mediator Network Analysis

Systems-level investigation of cytokine, chemokine, and mediator interactions to predict immunotherapy response and identify combination therapy opportunities.

Hypoxia-Inducible Factor Immunotherapy Targeting

Modulation of HIF-alpha signaling in immune cells to enhance anti-tumor immunity and overcome metabolic constraints in immunosuppressive microenvironments.

Cross-Reactive T Cell Response Prediction

Computational and experimental prediction of T cell cross-reactivity between self and foreign antigens to predict autoimmune and allergy risks.

Immunological Tolerance to Commensal Microbiota

Mechanistic analysis of how the immune system maintains tolerance to beneficial bacteria and application to therapeutic microbiota manipulation.

Engineered Extracellular Vesicle Immunotherapy

Development of therapeutically functionalized exosomes and microvesicles as immunomodulatory agents with enhanced cellular targeting and bioavailability.

Immune Dynamics in Organ Transplant Rejection

Temporal analysis of cellular and humoral immune responses during allograft rejection to develop predictive biomarkers and preventive strategies.

Nucleic Acid Sensing Pathway Modulation

Therapeutic targeting of cGAS-STING, RIG-I, and TLR pathways to enhance type I interferon responses in viral infections and cancer.

Immunological Consequences of Gene Therapy

Investigation of host immune responses to transgene products, delivery vectors, and engineered nucleic acids with strategies for tolerance induction.

Antigen-Specific Antibody Repertoire Mapping

Deep sequencing and bioinformatic analysis of B cell receptors and antibody repertoires following vaccination or infection to identify protective epitopes.

Immunometabolic Reprogramming in Cancer Immunity

Design of metabolic interventions targeting glucose, lipid, and amino acid metabolism in T cells to enhance anti-tumor immunity.

Therapeutic Antibody Tissue Penetration Engineering

Development of antibody variants with improved tumor and tissue penetration through size reduction, charge modification, and enhanced vascularization targeting.

Immune Response to Environmental Toxins

Characterization of how xenobiotics, heavy metals, and pollutants alter immune cell function and predispose to immunological diseases.

Lymph Node-Based Immunotherapy Targeting

Development of immunotherapeutic agents specifically designed to target secondary lymphoid organs for enhanced immunization and tolerance induction.

Engineered Probiotics for Immune Modulation

Design of recombinant bacterial strains expressing immunomodulatory factors for oral delivery to enhance mucosal and systemic immune responses.

Immune Cell Mechanical Properties and Function

Investigation of how cell stiffness, deformability, and mechanotransduction mechanisms influence T cell activation and effector functions.

Therapeutic Interferon Signaling Enhancement

Development of strategies to amplify interferon-alpha and interferon-gamma signaling pathways in immune and non-immune cells against viral and malignant diseases.

Immunological Tolerance to Allergens

Mechanistic studies of allergen tolerance acquisition and therapeutic induction of immune tolerance in allergic diseases through antigen-specific approaches.

Circulating Tumor DNA Immunogenicity

Investigation of immune recognition of cell-free tumor DNA and its role as danger-associated molecular pattern in cancer immunosurveillance.

Immune Priming Through Pattern Recognition Receptors

Optimization of innate immune activation through PRR ligands to enhance adaptive immune responses in cancer and infectious disease contexts.

Regulatory B Cell Induction and Function

Investigation of IL-10 and TGF-beta producing B cell populations and strategies for their therapeutic expansion in autoimmune and inflammatory diseases.

Immune Response to Biomaterial Implants

Characterization of foreign body reactions to implanted medical devices and development of immunomodulatory surface coatings to minimize rejection.

Metabolite-Mediated Immune Cell Programming

Identification of microbial and mammalian metabolites that direct immune cell differentiation and function for therapeutic metabolite supplementation strategies.

Immunosenescence Reversal via Thymic Regeneration

Therapeutic approaches to restore thymic epithelial cell function and naive T cell production in aged and immunocompromised populations.

Immune Contexture Prediction by Artificial Intelligence

Machine learning analysis of histopathological images and multi-omic data to predict immune cell composition and immunotherapy responsiveness.

Antigen Cross-Presentation Enhancement Strategies

Optimization of dendritic cell cross-presentation through antigen formulation, delivery, and costimulatory molecule upregulation for cancer vaccines.

Immunological Tolerance via Neonatal Exposure

Investigation of developmental immune tolerance mechanisms during neonatal period and application to early-life tolerance induction therapies.

Engineered Immune Cell Spatial Organization

Design of biomaterial scaffolds and tissue engineering approaches to organize immune cells in functional lymphoid-like structures.

Therapeutic Targeting of Immune Checkpoints in Stroma

Investigation of checkpoint molecule expression on stromal cells and development of therapies targeting fibroblast and endothelial-mediated immune suppression.

Immunological Biomarkers for Clinical Prediction

Identification and validation of blood-based and tissue immune signatures that predict disease progression, treatment response, and adverse events.

Immune Cell Senescence and Rejuvenation

Characterization of senescent immune cell markers and development of strategies to remove senescent cells or restore their function.

Immunogenicity of Engineered Food Proteins

Assessment of immune reactions to genetically modified and protein-engineered food products and development of hypoallergenic protein variants.

Trained Immunity and Innate Memory Formation

This research category focuses on harnessing the capacity of innate immune cells to develop long-lasting functional reprogramming and protective memory responses through metabolic and epigenetic modifications for enhanced disease prevention and therapeutic applications.